General Announcement::GPL approved the draft share purchase agreement to acquire 100 Per stake in Zorg Laboratories

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
29-May-2018 23:16:35
Status
New
Announcement Sub Title
GPL approved the draft share purchase agreement to acquire 100 Per stake in Zorg Laboratories
Announcement Reference
SG180529OTHRZKMS
Submitted By (Co./ Ind. Name)
GLENMARK PHARMACEUTICALS LTD.
Designation
COMPANY SECRETARY & COMPLIANCE OFFICER
Effective Date and Time of the event
30/05/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
GPL at its meeting held on May 29 2018, approved the draft share purchase agreement to acquire 100 Per stake in Zorg Laboratories Private Limited

Attachments

SGX_ACQ.pdf
Total size =1426K